Modification and Synergistic Studies of a Novel Frog Antimicrobial Peptide against Pseudomonas aeruginosa Biofilms

Xinze Liu,Daning Shi,Shiya Cheng,Xiaoling Chen,Chengbang Ma,Yangyang Jiang,Tao Wang,Tianbao Chen,Chris Shaw,Lei Wang,Mei Zhou
DOI: https://doi.org/10.3390/antibiotics13070574
2024-06-22
Antibiotics
Abstract:The overuse of traditional antibiotics has resulted in bacterial resistance and seriously compromised the therapeutic efficacy of traditional antibiotics, making the exploration of new antimicrobials particularly important. Several studies have shown that bioactive peptides have become an important source of new antimicrobial drugs due to their broad-spectrum antibacterial action and lack of susceptibility to resistance. In this study, a novel bioactive peptide Nigrosin-6VL was characterised from the skin secretion of the golden cross band frog, Odorrana andersonii, by using the 'shotgun' cloning strategy. Modifications on the Rana Box of Nigrosin-6VL revealed its critical role in antimicrobial functions. The peptide analogue, 2170-2R, designed to preserve the Rana Box structure while enhancing cationicity, exhibited improved therapeutic efficacy, particularly against Gram-negative bacteria, with a therapeutic value of 45.27. Synergistic studies demonstrated that 2170-2R inherits the synergistic antimicrobial activities of the parent peptides and effectively enhances the antimicrobial capacity of cefepime and gentamicin against both planktonic cells and biofilms. Specifically, 2170-2R can synergise effectively with cefepime and gentamicin against different strains of P. aeruginosa biofilms. Consequently, 2170-2R holds promise as a potent antimicrobial agent developed to combat infections induced by Pseudomonas aeruginosa.
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?
The problem this paper attempts to address is: the overuse of traditional antibiotics has led to increased bacterial resistance, severely weakening the therapeutic effects of conventional antibiotics. Therefore, exploring new antimicrobial agents has become particularly important. This paper aims to develop a new antimicrobial agent effective against Pseudomonas aeruginosa biofilm infections by studying a novel antimicrobial peptide Nigrosin-6VL and its derivative 2170-2R, discovered from the skin secretions of the golden-banded frog. Specifically, the study focuses on the following aspects: 1. **Discovery and Characterization of Novel Antimicrobial Peptide**: A novel antimicrobial peptide Nigrosin-6VL was identified from the skin secretions of the golden-banded frog (Odorrana andersonii), and its structure and function were characterized in detail. 2. **Peptide Modification and Optimization**: By modifying the Rana Box structure of Nigrosin-6VL, an improved peptide derivative 2170-2R was designed to enhance its antimicrobial activity, particularly against Gram-negative bacteria. 3. **Synergistic Antimicrobial Study**: The synergistic antimicrobial effect of 2170-2R in combination with existing antibiotics (such as cefepime and gentamicin) was studied, especially in combating Pseudomonas aeruginosa biofilms. 4. **Investigation of Antimicrobial Mechanism**: Experiments were conducted to explore the impact of Nigrosin-6VL and 2170-2R on bacterial cell membrane permeability, revealing their antimicrobial mechanisms. 5. **Evaluation of Anti-biofilm Activity**: The inhibitory effects of Nigrosin-6VL and 2170-2R on different bacterial biofilms were evaluated, particularly their inhibitory effect on Pseudomonas aeruginosa biofilms. In summary, this paper aims to develop a new antimicrobial agent capable of effectively combating Pseudomonas aeruginosa biofilm infections by discovering and optimizing novel antimicrobial peptides, thereby providing new ideas and methods for addressing the issue of antibiotic resistance.